Lv6
1940 积分 2022-05-05 加入
Impact of Hypovolemic Phlebotomy with Low Central Venous Pressure on Intraoperative Blood Loss in Open Liver Resection
2个月前
已完结
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors
2个月前
已完结
Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors after transplant: A prospective pilot trial
2个月前
已关闭
Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer
3个月前
已完结
Hepatocellular carcinoma
3个月前
已完结
Tumor Mutational Burden From Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection
3个月前
已完结
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation
4个月前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
4个月前
已完结
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
4个月前
已完结
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
4个月前
已完结
皖公网安备34019202002308
